Andrew Turner

Title: Andrew Turner - Innovator in Pharmaceutical Chemistry

Introduction

Andrew Turner is a notable inventor based in Holmes Chapel, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medication.

Latest Patents

Andrew holds a patent for a process titled "Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine." This innovative process focuses on the racemization of enantiomerically enriched 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine, which serves as a useful intermediate in the preparation of paroxetine. His work in this area is crucial for the development of effective pharmaceutical treatments.

Career Highlights

Andrew is currently employed at Aesica Pharmaceuticals Limited, where he continues to advance his research and development efforts. His expertise in pharmaceutical chemistry has positioned him as a valuable asset to his team and the industry.

Collaborations

Throughout his career, Andrew has collaborated with talented professionals, including Jayne Froggett and Dean Riley. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Andrew Turner exemplifies the spirit of innovation in pharmaceutical chemistry through his patent and contributions to Aesica Pharmaceuticals Limited. His work not only enhances the field but also plays a vital role in the development of important medications.